Same procedure every year – the year end review as part of the performance management appears on your calendar. Are you worried about filling in forms? Do you feel like this is not adding value?
In this episode, we give you practical tips how to master the review like a pro.
[Read more…] about How to prepare for your year end review to stand out!We’re launching a new leadership course next year and in this episode, we go into some key questions about statisticians and leadership.
We cover the following topics:
Today, regulatory approval doesn’t ensure anymore, that patients benefit from new therapies. As statisticians, we also need to ensure access and reimbursement for new treatments in the different markets around the world.
The process to gain this access and reimbursement in Germany comes with very specific challenges. Yet, due to the large impact of Germany on other countries via the complex reference pricing system and the size of the population of Germany, we must understand these topics.
Carsten Schwenke gathered experiences across therapeutic areas with many companies since the start of the new process in Germany. This makes him the most experienced and best connected statistician in the world for this topic.
[Read more…] about Getting access for patients to new medications in Germany – the biggest challenges in the HTA process and how to address them: Interview with Carsten SchwenkeWe’re all making decisions to optimize our studies. Optimizing project plans across different studies presents further challenges. But how to increase the overall portfolio of a company given its limitations leads yet another set of challenges. Knowing how decisions are taken at this top level helps to understand the bigger picture and why this sometimes implies sub-optimal decisions on a study or compound level.
[Read more…] about How to make the right portfolio decisions – Interview with Andreas Sashegyi
